Leading the Way in Glaucoma Treatment
We’re thrilled to announce Vision Quest Medical Center has become the first vision center in the state to implant the FDA approved iDose TR device for the treatment of glaucoma!
On May 14th, our team successfully performed the first-ever iDose TR implantation in Idaho. This groundbreaking device provides a new direction in open-angle glaucoma or ocular hypertension treatment, offering a long-term alternative to traditional eye drop regimens.
What is iDose TR?
Glaucoma is a leading cause of blindness, and managing it often involves using daily eye drops to lower intraocular pressure. However, eye drops can be a challenge to administer for many patients, can present uncomfortable side effects, and may come with complex dosing requirements. The iDose TR implant provides a simple alternative. This tiny device, implanted during a minimally invasive procedure, delivers a steady dose of medication directly into the eye over an extended time.
The first implant designed to deliver medication 24/7
Individually crafted with bio-compatible materials
Tested and proven to be safe and effective with minimal side effects.
Benefits of iDose TR
iDose TR offers a number of potential benefits, including:
- Alternative to eye drops: A game-changer for patients who have difficulty remembering or tolerating eye drops.
- Sustained medication: Provides long-term pressure control.
- Minimally invasive: Implantation is quick and safe.
81%
of iDose TR patients remained free of topical medication after 12 months.
Pioneering Glaucoma Care at Vision Quest Medical Center
iDose TR is redefining standards of care for glaucoma treatment. We’re proud to be first in Idaho to offer this innovative treatment to our patients and are committed to providing the latest advancements in vision care.
If you or a loved one are interested in learning if iDose TR may be a solution, contact our office below to schedule a consultation. Together, we can work towards a brighter future for your vision!
